CenterWatch is excited to introduce Asia-Pacific's Growing Role in Global Clinical Trials. The Asia-Pacific is becoming an integral part of global drug development, and in the future will take a leadership position on some global projects. CenterWatch created Asia-Pacific's Growing Role in Global Clinical Trials to provide you with in-depth information on the future of this region and how it you can be a part of it.
Topics Include:
- Regulatory and business landscape
- Market intelligence
- Drug and device pipeline in 2007
- Charts and figures
- Directory of CRO companies
- Size and growth for the following markets:
-Australia
-China
-India
-Japan
-South Korea
Asia-Pacific's Growing Role in Global Clinical Trials is perfect for:
- Biotech and pharmaceutical companies planning to enter the Asia-Pacific market
- Investment firms covering the life sciences industry in emerging markets
- CROs conducting business in Asia-Pacific countries
Learn what global biopharmaceutical executives and the heads of contract research organizations who have on-the-ground experience in the region say about the Asia-Pacific region.
To preview the Table of Contents and other sample pages, click on the links below:
Asia-Pacific’s Growing Role in Global Clinical Trials is available as a non-printable PDF or as a printed report. For additional information please call (866) 219-3440, ext 4 or email sales@centerwatch.com.
For a faxable order form click here
For multiple copies or site license information, please call (866) 219-3440, ext 4 or email sales@centerwatch.com. 
